STOCK TITAN

12,500,000-share deal shifts control at ClearOne (NASDAQ: CLRO) and adds new plan

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ClearOne, Inc. outlines several corporate actions tied to its planned acquisition of Cortigent. On August 4, 2026 it entered into a warrant cancellation agreement with First Finance Ltd., cancelling warrants to purchase up to 437,500 common shares at $5.00 per share that were exercisable for two years.

On July 31, 2026 ClearOne executed an employment agreement with chief financial officer Simon Brewer, effective upon completion of the Cortigent acquisition. The agreement provides a $300,000 annual base salary, eligibility for a discretionary bonus, and options for up to 200,000 shares at the price of related financing, vesting 25% on each anniversary of the employment agreement, plus six months salary and COBRA benefits if terminated without cause or if he resigns for good reason.

On August 3, 2026 First Finance Ltd., holding approximately 61.3% of the company’s voting power, delivered written consent approving issuance of 12,500,000 common shares in connection with the merger, representing more than 20% of outstanding common stock and resulting in a change of control under Nasdaq Listing Rules 5635(a) and 5635(b), and adopting the 2026 Omnibus Incentive Plan. ClearOne plans to complete these actions no earlier than 20 calendar days after mailing a Schedule 14C information statement to stockholders of record as of July 31, 2026.

Positive

  • Cancellation of 437,500 warrants at $5.00 per share with First Finance Ltd. removes a prior right to acquire common stock and eliminates that specific potential source of future dilution.

Negative

  • Written consent by First Finance Ltd. approves issuance of 12,500,000 new shares, exceeding 20% of existing common stock and resulting in a change of control under Nasdaq Listing Rules 5635(a) and 5635(b).

Insights

Analyzing...

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Cancelled Warrants 437,500 shares Warrants to purchase common stock cancelled as of August 4, 2026
Warrant Exercise Price $5.00 per share Exercise price of the cancelled warrants held by First Finance Ltd.
CFO Base Salary $300,000 per year Annual base salary for CFO Simon Brewer under the employment agreement
CFO Option Grant 200,000 shares Stock options to purchase common stock granted to the CFO, vesting 25% on each anniversary
Merger Share Issuance 12,500,000 shares Common stock to be issued in connection with the Agreement and Plan of Merger
Consenting Stockholder Holdings 1,641,162 shares Common shares of ClearOne held by First Finance Ltd. as of July 31, 2026
Consenting Stockholder Voting Power 61.3% Approximate voting power of ClearOne’s outstanding capital stock held by First Finance Ltd.
Schedule 14C Waiting Period 20 calendar days Minimum period after mailing Schedule 14C before stock issuance and plan adoption
warrant cancellation agreement financial
"entered into a warrant cancellation agreement with First Finance Ltd."
Agreement and Plan of Merger financial
"in connection with an Agreement and Plan of Merger dated as of July 1, 2026"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
2026 Omnibus Incentive Plan financial
"the adoption of the Company’s 2026 Omnibus Incentive Plan"
Schedule 14C regulatory
"will file with the Securities and Exchange Commission an information statement on Schedule 14C"
Schedule 14C is an SEC filing that companies use to send an official information statement to shareholders when they are not asking for proxy votes. It lays out key facts about corporate actions—such as reorganizations, related-party transactions, or changes in governance—so investors can understand what’s happening without being asked to vote, like receiving a detailed neighborhood notice about a rule change rather than a petition. Because it provides formal, regulated disclosure, Schedule 14C helps investors verify claims, weigh potential impacts on ownership or value, and hold management accountable.
Nasdaq Listing Rules 5635(a) and 5635(b) regulatory
"results in a change of control of the Company pursuant to Nasdaq Listing Rules 5635(a) and 5635(b)"
Nasdaq listing rules 5635(a) and 5635(b) require shareholder approval before a listed company issues new shares or convertible securities that would meaningfully increase the number of shares outstanding or give shares to insiders or large holders. Think of it like a building’s rules that require neighbors to sign off before adding extra apartments or giving a unit to a family member. For investors, these rules limit surprise dilution and curb self-dealing that can change ownership and share value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What warrants did ClearOne (CLRO) cancel with First Finance Ltd.?

ClearOne cancelled warrants held by First Finance Ltd. to purchase up to 437,500 shares of common stock at an exercise price of $5.00 per share. These warrants, originally exercisable for two years after issuance, were cancelled and extinguished effective August 4, 2026.

What are the key terms of Simon Brewer’s CFO employment agreement at ClearOne (CLRO)?

Simon Brewer’s agreement provides a $300,000 annual base salary, eligibility for a discretionary bonus, and options for up to 200,000 shares at the financing price, vesting 25% on each anniversary. If terminated without cause or he resigns for good reason, he receives six months salary and COBRA benefits.

How many new shares will ClearOne (CLRO) issue in connection with the Cortigent merger?

ClearOne obtained written consent to issue 12,500,000 shares of common stock in connection with the Agreement and Plan of Merger. This stock issuance exceeds 20% of the existing common stock and results in a change of control under Nasdaq Listing Rules 5635(a) and 5635(b).

Who is the consenting stockholder controlling ClearOne (CLRO) and what is their voting power?

The consenting stockholder is First Finance Ltd., which held 1,641,162 ClearOne common shares as of July 31, 2026. This position represented approximately 61.3% of the voting power of the company’s outstanding capital stock entitled to vote on the actions approved by written consent.

When will ClearOne (CLRO) complete the stock issuance and 2026 Omnibus Incentive Plan adoption?

ClearOne plans to effect the 12,500,000-share issuance and adoption of the 2026 Omnibus Incentive Plan no earlier than 20 calendar days after mailing a Schedule 14C information statement to stockholders of record as of July 31, 2026, in accordance with Rule 14c-2.

How was ClearOne’s 2026 Omnibus Incentive Plan approved and what else is disclosed?

The 2026 Omnibus Incentive Plan was approved by written consent of First Finance Ltd., which held about 61.3% of voting power. Its adoption is tied to the 12,500,000-share issuance for the merger, and the plan document will be appended to a Schedule 14C information statement.
false 0000840715 CLEARONE INC 00008407152026-07-312026-07-31

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): July 31, 2026

 

ClearOne, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

001-33660

 

87-0398877

(State or Other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

7533 S Center View Ct. # 5311, West Jordan, Utah

 

84084

(Address of principal executive offices)

 

(Zip Code)

 

+1 (801) 975-7200

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Securities Registered Pursuant to Section 12(b) of the Act:  

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001

CLRO

The NASDAQ Capital Market

 




Item 1.01              Entry into a Material Definitive Agreement.


On August 4, 2026, ClearOne, Inc. (the “Company”) entered into a warrant cancellation agreement (the “Warrant Cancellation Agreement”) with First Finance Ltd., whereby the Company and First Finance Ltd. agreed that warrants to purchase up to 437,500 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $5.00 per share for a period of two years following issuance are cancelled and extinguished as of August 4, 2026. The Warrant Cancellation Agreement was entered into in connection with an Agreement and Plan of Merger dated as of July 1, 2026 with CLRO Merger Sub, Inc., Cortigent, Inc. and Vivani Medical, Inc. (the “Merger Agreement”).


The foregoing description of the Warrant Cancellation Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Warrant Cancellation Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.


Item 5.02              Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers’ Compensatory Arrangements of Certain Officers.

On July 31, 2026, the Company entered into an employment agreement (the “Employment Agreement”) with Simon Brewer, the chief financial officer of the Company, whereby the Company has retained Mr. Brewer as the chief financial officer of the Company to be effective upon completion of the acquisition of Cortigent for an indefinite period, provided that either party may terminate the Employment Agreement upon providing the other party with 30 days’ prior written notice. Mr. Brewer is to be paid an annual base salary of $300,000 and is eligible for an annual discretionary performance bonus. The Company has agreed to grant to Mr. Brewer stock options to purchase up to 200,000 shares of Common Stock at an exercise price equal to the price of the financing to be completed in connection with the acquisition of Cortigent, which options will vest as to 25% on each anniversary of the Employment Agreement. Mr. Brewer is eligible to participate in any benefit plans offered by the Company. The Company may terminate the Employment Agreement with cause at any time by paying any unpaid salary and expenses/benefits. The Company may terminate the Employment Agreement without cause, or Mr. Brewer may resign for good reason (as defined in the Employment Agreement), on 30 days prior written notice, by paying any unpaid salary and expenses/benefits plus a severance payment of six months of the annual salary and continuing any COBRA benefits for such six month period. Mr. Brewer has agreed to not solicit employees or customers for a period of 12 months following any termination of the Employment Agreement and not to disparage the Company or its past or present officers, directors, managers, employees, products, services or business.

The foregoing description of the Employment Agreement does not purport to be complete and it is qualified in its entirety by reference to the full text of the Employment Agreement filed as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.


Item 5.07             Submission of Matters to a Vote of Security Holders.


On August 3, 2026, a stockholder (the “Consenting Stockholder”) of the Company holding at least a majority of the voting power of the Company’s outstanding shares of capital stock entitled to vote adopted resolutions by written consent (the “Written Consent”) in lieu of a meeting of stockholders to approve (i) the issuance of 12,500,000 shares of Common Stock (the “Stock Issuance”) in connection with the Merger Agreement, which represents more than 20% of the Common Stock outstanding and results in a change of control of the Company pursuant to Nasdaq Listing Rules 5635(a) and 5635(b), respectively; and (ii) the adoption of the Company’s 2026 Omnibus Incentive Plan (the “Plan Adoption”). In connection with the Stock Issuance and Plan Adoption, the Company will file with the Securities and Exchange Commission an information statement on Schedule 14C (the “Schedule 14C”) that will be mailed to all holders of record of the Company’s voting capital stock as of the close of business on July 31, 2026 (the “Record Date”). Copies of the Merger Agreement and the Company’s 2026 Omnibus Incentive Plan will be filed as appendices to the Schedule 14C.


The Consent Stockholder is First Finance, Ltd. As of the close of business on the Record Date, the Consenting Stockholder held 1,641,162 shares of the Company’s Common Stock, representing approximately 61.3% of the voting power of our outstanding shares of capital stock entitled to vote.


In accordance with Rule 14c-2 under the Securities Exchange Act of 1934, the Company plans to effectuate the Stock Issuance and Plan Adoption no earlier than twenty (20) calendar days after the commencement of mailing of the Schedule 14C to the Company’s stockholders.


Item 9.01              Financial Statements and Exhibits


(d)  Exhibits 

Exhibit Number

 

Exhibit Title

10.1
Warrant Cancellation Agreement, dated as of August 4, 2026, by and between ClearOne, Inc. and First Finance Ltd.
10.2
Employment Agreement, dated as of July 31, 2026, by and between ClearOne, Inc. and Simon Brewer.

104.1

 

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 




SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CLEARONE, INC.

 

 

 

Date:  August 5, 2026

By:

/s/ Simon Brewer

 

 

Simon Brewer

 

 

Chief Financial Officer


Filing Exhibits & Attachments

7 documents